论文部分内容阅读
目的:探讨肺部真菌感染的临床易感因素、临床表现、诊断及治疗措施。方法:回顾性分析2012年7月～2013年12月收治的24例肺部真菌感染患者,其临床表现、影像学表现、实验室检查、治疗及转归。结果:24例肺部真菌感染病例中,治愈18例,好转4例,死亡2例。结论:在临床诊治过程中应将COPD病人应列为高危险性患者,其病原谱本组患者以烟曲霉菌多见,且应用对菌群敏感的抗菌药物伏立康唑治疗后预后较好。
Objective: To investigate the clinical susceptibility factors, clinical manifestations, diagnosis and treatment of pulmonary fungal infections. Methods: Twenty-four patients with pulmonary fungal infection admitted from July 2012 to December 2013 were retrospectively analyzed. Their clinical manifestations, imaging findings, laboratory tests, treatment and prognosis were retrospectively analyzed. Results: In 24 cases of pulmonary fungal infections, 18 cases were cured, 4 cases improved, and 2 cases died. Conclusion: Patients with COPD should be classified as high-risk patients during clinical diagnosis and treatment. The patients with this pathogen spectrum are more common with Aspergillus fumigatus, and the application of voriconazole, which is sensitive to the flora, has a good prognosis.